Journal of Hepatocellular Carcinoma

https://www.dovepress.com/journal-of-hepatocellular-carcinoma-archive148

List of Papers (Total 49)

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Sorafenib plus tegafur-uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study) Hamdy A Azim,1 Ashraf Omar,2 Hesham Atef,1,† Heba Zawahry,3 Mohamed K Shaker,4 AH Kamel Abdelmaksoud,5 Mohamed EzzElarab,6 Omar Abdel-Rahman,7 Mohamed Ismail,8 Loay Kassem,1 Imam Waked9 1Department of Clinical Oncology...

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI) Victor Hugo Fonseca de Jesus, Aldo Lourenço Abbade Dettino Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil Abstract: At the 2018 Gastrointestinal Cancer Symposium, sponsored by the American Society of Clinical Oncology, significant advances in the management...

Hepatocellular cancer pain: impact and management challenges

Hepatocellular cancer pain: impact and management challenges Nathaniel Christian-Miller,1 Catherine Frenette2 1Scripps Clinical Research, Scripps, San Diego, CA, USA; 2Scripps Center for Organ and Cell Transplantation, Scripps Green Hospital, La Jolla, CA, USA Abstract: Hepatocellular carcinoma (HCC) remains the most common primary liver malignancy. Pain comprises one of the most...

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Role of Wnt/beta-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance Ahmed M Khalaf,1 David Fuentes,1 Ali I Morshid,2 Mata R Burke,3 Ahmed O Kaseb,4 Manal Hassan,4 John D Hazle,1 Khaled M Elsayes2 1Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Diagnostic Radiology, University of...

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance Anna S Griffith,1 Paul H Hayash,1 Lauren MB Burke,2 Autumn J McRee1 1Department of Medicine, 2Department of Radiology, University of North Carolina at Chapel Hill Hospital, Chapel Hill, NC, USA...

Basic MRI for the liver oncologists and surgeons

Basic MRI for the liver oncologists and surgeons Lan N Vu,1 John N Morelli,2 Janio Szklaruk1 1Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Radiology, St. John’s Medical Center, Tulsa, OK, USA Abstract: Magnetic resonance imaging (MRI) is the modality of choice for liver imaging due to its superior contrast resolution...

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma Bin Liang,1,2 Siyang Yao,2 Jiapeng Zhou,3 Zongkui Li,1,2 Tianqi Liu2 1Department of Graduate School, The Guangxi Medical University, 2Department of Hepatobiliary Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, 3Department of Hepatobiliary...

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma Lynn G Feun,¹ Medhi Wangpaichitr,² Ying-Ying Li,¹ Deukwoo Kwon,³ Stephen P Richman,¹ Peter J Hosein,¹ Niramol Savaraj¹,² ¹Department of Medicine, Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, ²Department of Surgery, Miami VA Healthcare System, Research...

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator Jeremiah Suryatenggara,1,2 Heri Wibowo,2 Wahyuni Lukita Atmodjo,3 George Mathew1,3 1Mochtar Riady Institute for Nanotechnology and Medical Science Group, Pelita Harapan University, Tangerang, 2Biomedical Science Graduate Programme, Faculty of Medicine, University...

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions Emily M Ray, Hanna K Sanoff Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA Abstract: The only US Food and Drug Administration (FDA)-approved first-line systemic therapy for hepatocellular carcinoma (HCC) is sorafenib...

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma Waleed Fateen,1,2 Farooq Khan,1 Richard J O’Neill,3 Martin W James,1 Stephen D Ryder,1 Guruprasad P Aithal1,2 1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, 2Nottingham Digestive Diseases Centre, University of...

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect Andrew N de la Torre,1,2 Sohail Contractor,3 Ismael Castaneda,1 Charles S Cathcart,4 Dolly Razdan,5 David Klyde,3 Piotr Kisza,3 Sharon F Gonzales,3 Andres M...

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review Rodolfo Sacco,1 Gherardo Tapete,1 Natalia Simonetti,1 Rossella Sellitri,1 Veronica Natali,1 Sara Melissari,1 Giuseppe Cabibbo,2 Lilia Biscaglia,3 Giampaolo Bresci,1 Luca Giacomelli4 1Department of Gastroenterology, Pisa University Hospital, Pisa, 2University of Palermo, Palermo, 3Department of...

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies Danijel Galun,1,2 Tatjana Srdic-Rajic,3 Aleksandar Bogdanovic,1 Zlatibor Loncar,2,4 Marinko Zuvela1,2 1Hepato-Pancreato-Biliary Unit, University Clinic for Digestive Surgery, Clinical Center of Serbia, 2Medical School, University of Belgrade, 3Institute...

Hepatocellular carcinoma: early-stage management challenges

Hepatocellular carcinoma: early-stage management challenges Derek J Erstad,1 Kenneth K Tanabe2–4 1Department of Surgery, Massachusetts General Hospital, 2Harvard Medical School, 3Division of Surgical Oncology, 4Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA, USA Abstract: Hepatocellular carcinoma (HCC) is a major cause of cancer death and...

Screening for hepatocellular carcinoma: patient selection and perspectives

Screening for hepatocellular carcinoma: patient selection and perspectives Waleed Fateen, Stephen D Ryder NIHR Biomedical Research Unit in Gastrointestinal and Liver Diseases, Nottingham University Hospitals NHS Trust, The University of Nottingham, Nottingham, UK Abstract: Hepatocellular carcinoma (HCC) develops on the background of liver cirrhosis often from multiple...

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma (HCC) receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L Marina G Tarakanovskaya,1 Jigjidsuren Chinburen,2 Purev Batchuluun,2 Chogsom Munkhzaya,2 Genden Purevsuren,2 Dorjiin Dandii,3 Tsogkhuu Hulan,3 Dandii Oyungerel,4 Galyna A Kutsyna,5 Alan A Reid,6 Vika Borisova,6...

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives Asha Zimmerman,1 David Grand,2 Kevin P Charpentier 1 1Department of Surgery, 2Department of Radiology, Rhode Island Hospital, Brown University, Providence, RI, USA Abstract: Irreversible electroporation (IRE) is a novel form of tissue ablation that uses high-current electrical pulses to...

A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus

A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus Anon Chotirosniramit, Akkaphod Liwattanakun, Worakitti Lapisatepun, Wasana Ko-iam, Trichak Sandhu, Sunhawit Junrungsee Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand Background: Obstructive...

Liver Imaging Reporting and Data System: an expert consensus statement

Liver Imaging Reporting and Data System: an expert consensus statement Khaled M Elsayes,1 Ania Z Kielar,2 Michelle M Agrons,3 Janio Szklaruk,1 An Tang,4 Mustafa R Bashir,5 Donald G Mitchell,6 Richard K Do,7 Kathryn J Fowler,8 Victoria Chernyak,9 Claude B Sirlin10 1Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department...

Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge

Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge Giampiero Francica Interventional Ultrasound Unit, Department of Radiology, Pineta Grande Hospital, Castel Volturno, Italy Abstract: Neoplastic seeding may arise after radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). A low risk of seeding...

Pediatric hepatocellular carcinoma: challenges and solutions

Pediatric hepatocellular carcinoma: challenges and solutions Irene Schmid,1 Dietrich von Schweinitz,2 1Department of Pediatric Hematology and Oncology, 2Department of Pediatric Surgery, Dr. von Hauner Children`s Hospital, Ludwig-Maximilians-University, Munich, Germany Abstract: Hepatocellular carcinoma (HCC) is a very rare entity in children, making it nearly impossible to...

GPC-3 in hepatocellular carcinoma: current perspectives

GPC-3 in hepatocellular carcinoma: current perspectives Yongle Wu,1 Hui Liu,2 Huiguo Ding1 1Department of Gastroenterology and Hepatology, 2Department of Pathology, Beijing You’an Hospital, Affiliated with Capital Medical University, Beijing, People’s Republic of China Abstract: Glypican-3 (GPC3), a member of heparan sulfate proteoglycans, attaches to the cell membrane and is...

Minimally invasive image-guided therapies for hepatocellular carcinoma

Minimally invasive image-guided therapies for hepatocellular carcinoma Mohamed E Abdelsalam,1 Ravi Murthy,1 Rony Avritscher,1 Armeen Mahvash,1 Michael J Wallace,1 Ahmed O Kaseb,2 Bruno C Odisio,1 1Department of Interventional Radiology, 2Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Abstract: Hepatocellular carcinoma (HCC) is...

Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary

Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary Gerald J Mizejewski Wadsworth Center, New York State Department of Health, Albany, NY, USA Abstract: The fifth most common cancer worldwide is hepatocellular carcinoma (HCC), while being the third leading cause of global cancer-related deaths. Although HCC incidence is...